
Metformin is a widely used medication to treat type 2 diabetes, but its mechanisms of action are complex and not fully understood. Metformin's efficacy and safety in T2DM have led to investigations into its potential use as an adjunct therapy for cancer, age-related diseases, inflammatory diseases, and COVID-19. Its mechanisms of action vary depending on dosage and duration of treatment. While early research suggested that the liver was the primary target, current research indicates that the gastrointestinal tract, gut microbiome, and tissue-resident immune cells also play important roles. Recent studies also identified a novel target at low metformin concentrations at the lysosome surface. The review highlights the latest advances in understanding metformin's mechanisms of action and its potential therapeutic uses.
Like
Save
Share